These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21274)

  • 1. Biochemical interaction between anorectic drugs and piribedil.
    Jori A; Dolfini E
    J Pharm Pharmacol; 1977 Sep; 29(9):581-2. PubMed ID: 21274
    [No Abstract]   [Full Text] [Related]  

  • 2. On the effect of anorectic drugs on striatum homovanillic acid in rats.
    Jori A; Dolfini E
    Pharmacol Res Commun; 1974 Apr; 6(2):175-8. PubMed ID: 4438398
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance to the increase of striatal homovanillic acid elicited by several anorectic drugs.
    Jori A; Dolfini E
    Eur J Pharmacol; 1977 Feb; 41(4):443-5. PubMed ID: 844486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic-cholinergic interaction in the striatum: studies with piribedil.
    Consolo S; Fanelli R; Garattini S; Ghezzi D; Jori A; Ladinsky H; Marc V; Samanin R
    Adv Neurol; 1975; 9():257-72. PubMed ID: 1146657
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of piribedil and one of its metabolites on the concentration of homovanillic acid in the rat brain.
    Jori A; Cecchetti G; Dolfini E; Monti E; Garattini S
    Eur J Pharmacol; 1974 Jul; 27(2):245-8. PubMed ID: 4851685
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
    Ponzio F; Achilli G; Perego C; Algeri S
    Neurosci Lett; 1981 Nov; 27(1):61-7. PubMed ID: 7329624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of food intake by piribedil in the rat: relation to dopamine receptor stimulation.
    Carruba MO; Ricciardi S; Mantegazza P
    Life Sci; 1980 Sep; 27(13):1131-40. PubMed ID: 6252402
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.
    Martres MP; Costentin J; Baudry M; Marcais H; Protais P; Schwartz JC
    Brain Res; 1977 Nov; 136(2):319-37. PubMed ID: 922486
    [No Abstract]   [Full Text] [Related]  

  • 9. Piribedil: behavioural, neurochemical and clinical profile of a dopamine agonist.
    Dourish CT
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):3-27. PubMed ID: 6304814
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased release of striatal dopamine after long-term treatment with methadone in rats: inhibition by agents which increase central 5-hydroxytryptamine transmission.
    Spampinato U; Nowakowska E; Samanin R
    J Pharm Pharmacol; 1983 Dec; 35(12):831-3. PubMed ID: 6141252
    [No Abstract]   [Full Text] [Related]  

  • 11. Piribedil and apomorphine: pre- and postsynaptic effects on dopamine synthesis and neuronal activity.
    Walters JR; Bunney BS; Roth RH
    Adv Neurol; 1975; 9():273-84. PubMed ID: 167566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of piribedil on body temperature in mice and rats.
    Kapturkiewicz Z; Sowińska H
    Pol J Pharmacol Pharm; 1977; 29(6):609-18. PubMed ID: 600860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ensaculin on dopamine metabolite levels and K(+)-induced glutamate release.
    Teismann P; Ferger B
    Eur J Pharmacol; 2000 Jun; 398(2):247-50. PubMed ID: 10854836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties.
    Uzan A; Le Fur G; Mitrani N; Kabouche M; Donadieu AM
    Life Sci; 1978 Jul; 23(3):261-73. PubMed ID: 29181
    [No Abstract]   [Full Text] [Related]  

  • 16. Piribedil-induced anti-hypoxic protection in rats.
    Saligaut C; Moore N; Daoust M; Chretien P; Boismare F
    Aviat Space Environ Med; 1982 Jan; 53(1):35-9. PubMed ID: 7055488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in striatal acetylcholine levels in vivo by piribedil a new dopamine receptor stimulant.
    Ladinsky H; Consolo S; Garattini S
    Life Sci; 1974 Apr; 14(7):1251-60. PubMed ID: 4823638
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in mesolimbic homovanillic acid content following discrete modulation of striatal dopamine systems [proceedings].
    Costall B; Naylor RJ
    Br J Pharmacol; 1979 May; 66(1):105P-106P. PubMed ID: 454900
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of drugs on metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Mar; 53(3):460P. PubMed ID: 1169083
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of dopamine, apomorphine and piribedil on the mesenterial blood flow of the cat.
    György L; Dóda M
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):22-32. PubMed ID: 4026462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.